Moolec Science Announces ‘Piggy Sooy’ Soy Platform Capable of Producing Significantly Higher Pork Protein

Luxembourg. June 26, 2023 – Moolec Science SA (NASDAQ: MLEC, “we”, “Moolec”), a science-based food ingredients company focused on the production of animal proteins in plants using molecular farming techniques, Today we announced outstanding results in meat substitutes. A program for the soy platform because the new “Piggy Sooy” produced a very large amount of pork protein.

Animal protein reached high expression levels of up to 26.6% of total soluble protein in soybean seeds, four times higher than the company’s initial forecast. Murek’s soybeans are the same pink color as pigs, so you can directly observe the results (click to access image) here). Following this achievement, the company’s soybean platform was renamed “Piggy Sooy.”

This breakthrough led Moolec to file a new patent using a new approach aimed at providing the company with a frictionless regulatory pathway going forward.

Moolec CEO and co-founder Gastón Paladini said: “Piggy Sooy represents visible, tangible evidence that Moolec’s technology has the ability to achieve significant yields for meat protein production in plants. Moolec strengthens its position as category creator, stating, “We are pioneers of molecular farming in the food industry. Our plant biology team is writing the history of the science of food and we couldn’t be more proud of them.”

Considering that plants can function as animal protein factories in a more efficient way than originally expected, this scientific milestone paves the way for molecular farming as one of the most valuable alternative techniques for producing animal proteins. is what makes it firm. The increased efficiency of this plant could improve the economics of our business model.

Moolec Science produces several meat proteins in plants as functional ingredients to improve the taste, appearance, texture and nutrition of meat substitutes. The company also emphasized that their enhanced functionality and end-uses may allow these food ingredients to be commercialized within the up to $600 billion traditional meat processing industry.

“This achievement sets a precedent for the entire scientific community aiming to achieve high levels of protein expression in seeds by molecular farming,” said Dr. Amit Dingra, Chief Scientific Officer of Moolec. He further emphasized that: “Mourek has developed a unique, successful and patentable platform for the expression of highly valuable proteins in the seeds of economically important crops such as soybeans. for a wide range of industries, including pharmaceutical, cosmetics, diagnostics, and other food industries. ”

About Moolec Science SA

Moolec is a science-based food ingredient company focused on producing animal protein in plants through molecular farming, a disruptive technology in the field of alternative proteins. The aim is to upgrade the taste, nutrition and affordability of alternative protein products while building a more sustainable and equitable food system. Our technological approach aims to have the cost structure of plant-based solutions with the sensory properties and functionality of animal-based solutions. Moolec’s technology has been in development for over ten years and is known as a pioneer in producing bovine protein from crops for the food industry. The company’s product portfolio and pipeline leverage the agricultural efficiencies of widely used target crops such as safflower, soybeans and peas. Moolec has a growing international patent portfolio of 24 granted and pending molecular farming technologies. The company is run by a diverse team of PhDs and food professionals with operations in the United States, Europe and South America. For more information, please visit: moolecscience.com.

Forward-Looking Statements

This press release contains “forward-looking statements”. Forward-looking statements are identified by the use of words such as “expect,” “intend,” “pursue,” “goal,” “anticipate,” “believe,” “anticipate,” “estimate,” “plan,” and similar words. There are cases. “forecasts”, “plans” and other similar expressions that predict or indicate future events or trends or are not statements of historical matters; Forward-looking statements regarding Moolec’s performance, prospects, earnings and other aspects of its business are predictions, forecasts and other statements regarding future events that are based on current expectations and assumptions and are, as a result, subject to risks. Thing. and uncertainty. We believe we have

Although each of the forward-looking statements contained in this press release has a reasonable basis, please be aware that these statements are based on a combination of facts and factors in which we are not certain. No assurance can be given that the forward-looking statements in this press release are accurate. These forward-looking statements involve a number of factors that could cause actual results to differ materially from those expected, including changes in applicable laws and regulations and the possibility that Murek may be adversely affected by economic factors. Subject to significant risks and uncertainties. business and/or other competitive factors, costs associated with Moolec’s expansion of its business, and other risks and uncertainties (see “Risk Factors” heading in Moolec’s Annual Report on Form 20 filed with the U.S. Stock Exchange); ) Commission (“SEC”), and Moolec’s other filings with the SEC. Should one or more of these risks or uncertainties materialize, or if any of our assumptions prove incorrect, actual results will be those projected in these forward-looking statements. may differ in important respects. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Therefore, do not place undue reliance on these statements.

Murek Media Contacts

  • Catalina Jones – comms@moolecscience.com

  • Edmond Lococo – Edmond.Lococo@icrinc.com

Murek Investor Contact

  • Martin Tarachuk – ir@moolecscience.com

  • Michael Bowen, ICR, LLC – MoolecIR@icrinc.com



Source

Share.

TOPPIKR is a global news website that covers everything from current events, politics, entertainment, culture, tech, science, and healthcare.

Leave A Reply

Exit mobile version